| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |